Arsenale Bioyards secures $10m to lower biomanufacturing costs
Arsenale Bioyards has successfully completed its $10 million seed funding round and its innovative approach to biomanufacturing. It highlights the…
From cells to real meat
Arsenale Bioyards has successfully completed its $10 million seed funding round and its innovative approach to biomanufacturing. It highlights the…
The Cultivated B has developed TCB-32, a synthetic molecule that could significantly reduce costs for cultivated meat and other cell-based…
Since insulin produced by genetically engineered bacteria—rather than the pancreases of slaughtered animals—was first approved in 1982, the market for…